Gabbropas en es it fr

Gabbropas Brand names, Gabbropas Analogs

Gabbropas Brand Names Mixture

  • No information avaliable

Gabbropas Chemical_Formula


Gabbropas RX_link

Gabbropas fda sheet

Gabbropas msds (material safety sheet)

Gabbropas MSDS

Gabbropas Synthesis Reference

Biniecki S., et al. Acta Pol Pharm. 1967;24(5):469-73

Gabbropas Molecular Weight

153.135 g/mol

Gabbropas Melting Point

150.5 oC

Gabbropas H2O Solubility

1690 mg/L

Gabbropas State


Gabbropas LogP


Gabbropas Dosage Forms

Packet of coated granules

Gabbropas Indication

For the treatment of tuberculosis

Gabbropas Pharmacology

Aminosalicylic acid is an anti-mycobacterial agent used with other anti-tuberculosis drugs (most often isoniazid) for the treatment of all forms of active tuberculosis due to susceptible strains of tubercle bacilli. The two major considerations in the clinical pharmacology of aminosalicylic acid are the prompt production of a toxic inactive metabolite under acid conditions and the short serum half life of one hour for the free drug. Aminosalicylic acid is bacteriostatic against Mycobacterium tuberculosis (prevents the multiplying of bacteria without destroying them). It also inhibits the onset of bacterial resistance to streptomycin and isoniazid.

Gabbropas Absorption

No information avaliable

Gabbropas side effects and Toxicity

LD50=4 gm/kg (orally in mice); LD50=3650 mg/kg (orally in rabbits)

Gabbropas Patient Information

Gabbropas Organisms Affected